Personalized Genomic Medicine Research Center, Daejeon, South Korea.
Korea Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea.
Genes Genomics. 2022 Aug;44(8):967-979. doi: 10.1007/s13258-022-01275-4. Epub 2022 Jun 25.
Colorectal cancer (CRC) is the third most common type of diagnosed cancer in the world and has the second-highest mortality rate. Meanwhile, South Korea has the second-highest incidence rate for CRC in the world.
To assess the possible influence of ethnicity on the molecular profile of colorectal cancer, we compared genomic and transcriptomic features of South Korean CRCs with European CRCs.
We assembled a genomic and transcriptomic dataset of South Korean CRC patients (KOCRC; n = 126) from previous studies and European cases (EUCRC; n = 245) selected from The Cancer Genome Atlas (TCGA). Then, we compared the two datasets in terms of clinical data, driver genes, mutational signature, gene sets, consensus molecular subtype, and fusion genes.
These two cohorts showed similar profiles in driver mutations but differences in the mutation frequencies of some driver genes (including APC, TP53, PABPC1, FAT4, MUC7, HSPG2, GNAS, DENND5B, and BRAF). Analysis of hallmark pathways using genomic data sets revealed further differences between these populations in the WNT, TP53, and NOTCH signaling pathways. In consensus molecular subtype (CMS) analyses of the study cases, no BRAF mutations were found in the CMS1 subtype of KOCRC, which contrasts with previous findings. Fusion gene analysis identified oncogenic fusion of PTPRK-RSPO3 in a subset of KOCRC patients without APC mutations.
This study presents insights into the genomic landscape of KOCRCs and reveals some similarities and differences with EUCRCs at the molecular level.
结直肠癌(CRC)是世界上第三大常见的癌症类型,死亡率居第二位。同时,韩国是世界上 CRC 发病率第二高的国家。
为了评估种族差异对结直肠癌分子谱的可能影响,我们比较了韩国 CRC 与欧洲 CRC 的基因组和转录组特征。
我们从之前的研究中收集了韩国 CRC 患者(KOCRC;n=126)的基因组和转录组数据集,并从癌症基因组图谱(TCGA)中选择了欧洲病例(EUCRC;n=245)。然后,我们比较了这两个数据集在临床数据、驱动基因、突变特征、基因集、共识分子亚型和融合基因方面的差异。
这两个队列在驱动突变方面表现出相似的特征,但在一些驱动基因的突变频率上存在差异(包括 APC、TP53、PABPC1、FAT4、MUC7、HSPG2、GNAS、DENND5B 和 BRAF)。使用基因组数据集分析标志性通路显示,这两个群体在 WNT、TP53 和 NOTCH 信号通路方面存在进一步的差异。在研究病例的共识分子亚型(CMS)分析中,KOCRC 的 CMS1 亚型中未发现 BRAF 突变,这与之前的发现相反。融合基因分析发现 KOCRC 患者中存在 PTPRK-RSPO3 的致癌融合,而这些患者中没有 APC 突变。
本研究揭示了 KOCRC 的基因组景观,并在分子水平上揭示了与 EUCRC 的一些相似和不同之处。